Michael E. Salacz
Impact in
- Genetics top 1%
- Glioma Diagnosis and Treatment
- Virus-based gene therapy research
- Immunology top 10%
- Immunotherapy and Immune Responses
Papers in
- Co-authors
- Peggy A. Ward-Smith (1 shared paper)James Perry (1 shared paper)Rafal Tarnawski (1 shared paper)Do Hyun Nam (1 shared paper)Monika E. Hegi (1 shared paper)Roberta Depenni (1 shared paper)Benoît Lhermitte (1 shared paper)Christine Hicking (1 shared paper)
- Journals
- Neuro-Oncology (4 papers)Journal of Palliative Medicine (3 papers)JAMA Oncology (2 papers)Blood (1 paper)Medical Oncology (1 paper)
- Partner nations
- United StatesGermanySwitzerland
In The Last Decade
Michael E. Salacz
25 papers receiving 1.6k citations
Michael E. Salacz's Hit Papers
Peers
Comparison fields: 5 of 79
- Genetics 861
- Immunology 263
- Pharmacy 42
- Oncology 236
- Hematology 130
Countries citing papers authored by Michael E. Salacz
This map shows the geographic impact of Michael E. Salacz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael E. Salacz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael E. Salacz more than expected).
Fields of papers citing papers by Michael E. Salacz
This network shows the impact of papers produced by Michael E. Salacz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael E. Salacz. The network helps show where Michael E. Salacz may publish in the future.
Co-authors
The 25 scholars most cited alongside Michael E. Salacz, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 26 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | First results on survival from a large Phase 3 clinical trial of an autologous dendritic cell vaccine in newly diagnosed glioblastoma Hit paper breakdown → | 2018 | 460 |
| 2 | Association of Autologous Tumor Lysate-Loaded Dendritic Cell Vaccination With Extension of Survival Among Patients With Newly Diagnosed and Recurrent Glioblastoma Hit paper breakdown → | 2022 | 334 |
| 3 | 2015 | 213 | |
| 4 | 2004 | 128 | |
| 5 | 2020 | 113 | |
| 6 | 2014 | 68 | |
| 7 | 2008 | 67 | |
| 8 | 2019 | 67 | |
| 9 | 2017 | 43 | |
| 10 | 2018 | 32 | |
| 11 | 2016 | 30 | |
| 12 | 2022 | 15 | |
| 13 | Glioblastoma: Part I. Current state of affairs. | 2011 | 14 |
| 14 | 2007 | 12 | |
| 15 | 2005 | 11 | |
| 16 | 2016 | 10 | |
| 17 | 2006 | 8 | |
| 18 | 2016 | 8 | |
| 19 | 2018 | 7 | |
| 20 | Glioblastoma. Part II: Future directions. | 2011 | 6 |
About Michael E. Salacz
Michael E. Salacz is a scholar working on Genetics, Oncology, Public Health, Environmental and Occupational Health, Pharmacy and Anesthesiology and Pain Medicine, having authored 26 papers that have together received 1.7k indexed citations. Recurring topics across this work include Glioma Diagnosis and Treatment (15 papers), Cancer survivorship and care (2 papers), Cancer, Hypoxia, and Metabolism (1 paper), Nursing care and research (1 paper), Empathy and Medical Education (1 paper), Blood transfusion and management (1 paper), Family Support in Illness (1 paper) and Cancer Immunotherapy and Biomarkers (1 paper). The work is most often cited by research in Genetics (861 citations), Immunology (263 citations), Pharmacy (42 citations), Oncology (236 citations) and Hematology (130 citations). Michael E. Salacz has collaborated with scholars based in United States, Germany and Switzerland. Frequent co-authors include Peggy A. Ward-Smith, James Perry, Rafal Tarnawski, Do Hyun Nam, Monika E. Hegi, Roberta Depenni, Benoît Lhermitte, Christine Hicking, David A. Reardon and Karen Fink. Their work appears in journals such as Neuro-Oncology, Journal of Palliative Medicine, JAMA Oncology, Blood and Medical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.